El foro MCS destaca la estrategia para 2026, las alianzas y el crecimiento
Health insurer MCS gathered more than 200 business partners at its Commercial Forum 2026, positioning the annual event as a venue to outline priorities for the coming year and discuss Puerto Rico’s economic and organizational outlook.
Held Oct. 24 at the Hilton Garden Inn San Juan, the event brought together producers, agents and clients to discuss market performance, regulatory changes, service expectations and evolving clinical demands.
During the forum, MCS emphasized operational stability, product development, clinical programs and service efficiency as areas of focus within the commercial health insurance market.
The company reported serving more than 2,800 businesses and 630,000 members across its commercial and Medicare Advantage divisions.
A fireside chat led by senior executives opened the program with discussion of financial results, provider network access, service quality and institutional trust. Presentations also covered changes in pharmacy benefits, cost pressures and expectations for 2026.
One of the most detailed sessions, led by Chief Pharmacy Officer Carolyn Rodríguez, examined how employers and brokers can navigate the changing pharmacy landscape.
“The future of pharmacy in Puerto Rico depends on informed and collaborative decisions,” Rodríguez said, noting that “although commercial premiums are 60% lower in Puerto Rico compared to the U.S. average, medication prices are the same.”
She added that MCS’s priority is “to operate a sophisticated system that ensures patient-centered access and care coordination,” supported by more than 1.8 million prescriptions managed each month.
MCS also discussed its wellness programs and provider network.
“We have 67 contracted hospitals and a network of over 15,000 providers,” said Chief Operating Officer Roberto Torres, adding that the company’s MCS Care Clubs combine preventive services, clinical care and specialist support throughout the island.
The forum concluded with a review of regulatory, tax and labor measures that could affect commercial plans in 2026.
